MOQ : 5 Pack(s)
Business Type : Manufacturer, Exporter
Product Details
| Type | Tablets |
| Purity | 99% |
| Usage | Imutrex 7.5 Mg is not recommended for use in patients with gastrointestinal disorders like diarrhea and ulcerative stomatitis. |
| Name | Imutrex 7.5mg Tablets |
| MOQ | 5 |
| Product | Cipla |
Additional Information
| Port | Mumbai |
| Payment Terms | T/T, Western Union, MoneyGram |
| Delivery Time | 5 - 7 working days |
| Packaging Details | Tablet pack in bubble envelop. |
Preferred Buyer From
| Location | All Countries Except India |
Imutrex contains Methotrexate, abbreviated MTX and formerly known as amethopterin, is an antimetabolite and antifolate drug used in treatment of cancer and autoimmune diseases. It acts by inhibiting the metabolism of folic acid. Methotrexate began to replace the more powerful and toxic antifolate aminopterin starting in the 1950s, and the two should not be confused with each other.
Pharmacodynamics Pharmacokinetics : Methotrexate is a folic acid antagonist that inhibits DNA synthesis. It irreversibly binds to dihydrofolate reductase, inhibiting the formation of reduced folates, and thymidylate synthetase, resulting in inhibition of purine and thymidylic acid synthesis.
